Scan to download

202308561
Mr. ABDUL SAMAD
Age / Sex : 29 YRS / M Registered on : 02/12/2024 06:55 PM
Collected on : 02/12/2024 06:55 PM
Referred by : Dr. K ANUPAM GARU (BDS., MDS., (Dental Surgeon))
Received on : 02/12/2024 06:57 PM
Visit ID : : 202308561
Reported on : 03/12/2024 02:54 PM

DEPARTMENT OF HAEMATOLOGY
TEST VALUE UNIT REFERENCE
BLEEDING TIME (BT) 2:15 min 2-7

CLOTTING TIME (CT) 4:00 min 4-9

DEPARTMENT OF BIOCHEMISTRY
LIVER FUNCTION TEST (LFT)
TEST VALUE UNIT REFERENCE
SERUM BILIRUBIN (TOTAL) 0.64 mg/dl 0.2 - 1.2
Method: Bergh&Muller

SERUM BILIRUBIN (DIRECT) 0.17 mg/dl 0 - 0.3

Method: Bergh&Muller

SERUM BILIRUBIN (INDIRECT) 0.47 mg/dl 0.2 - 1

Method: Calculation

SGPT (ALT) 19.46 U/I 10 - 40

Method: IFCC Kinetic

SGOT (AST) 21.09 U/I 0 - 37

Method: IFCC Kinetic

SERUM ALKALINE PHOSPHATASE 117.52 U/I 44 - 147

Method: PNPP/AMP KINETIC

SERUM PROTEIN 7.30 g/dl 6.4 - 8.3

Method: BIURET

SERUM ALBUMIN 4.51 g/dl 3.5 - 5.2

Method: BCG (Bromocresol Green)

GLOBULIN 2.79 g/dl 1.8 - 3.6

Method: CALCULATION

A/G RATIO 1.62 1.1 - 2.1

Method: CALCULATION

Note : In an asymptomatic patient, Non alcoholic fatty liver disease (NAFLD) is the most common cause of increased AST,
ALT levels. NAFLD is considered as hepatic manifestation of metabolic syndrome. In most type of liver disease, ALT activity is
higher than that of AST; exception may be seen in Alcoholic Hepatitis, Hepatic Cirrhosis, and Liver neoplasia. In a patient with
Chronic liver disease, AST:ALT ratio>1 is highly suggestive of advanced liver fibrosis. In known cases of Chronic Liver disease
due to Viral Hepatitis B & C, Alcoholic liver disease or NAFLD, Enhanced liver fibrosis (ELF) test may be used to evaluate liver
fibrosis. In a patient with Chronic Liver disease, AFP and Des-gamma carboxyprothrombin (DCP)/PIVKA II can be used to
assess risk for development of Hepatocellular Carcinoma. Test results released pertain to the specimen submitted . All test

Verified by. Authorised by.

Mr. RAJU MEDISETTI Mr. V RAJESH,
M.Sc(Microbiology),DMLT. Page 1 of 5 M.Sc(Biochemistry), B.Sc MLT.
 Scan to download
202308561
Mr. ABDUL SAMAD
Age / Sex : 29 YRS / M Registered on : 02/12/2024 06:55 PM
Collected on : 02/12/2024 06:55 PM
Referred by : Dr. K ANUPAM GARU (BDS., MDS., (Dental Surgeon))
Received on : 02/12/2024 06:57 PM
Visit ID : : 202308561
Reported on : 03/12/2024 02:54 PM

results are dependent on the quality of the sample received by the Laboratory .

TEST VALUE UNIT REFERENCE

BLOOD SUGAR - RANDOM 130.1 mg/dl Normal: 70 - 160
Method: (Glucose Oxidase/ Peroxidase) Diabetic: >= 161

DEPARTMENT OF HEMATOLOGY AND COAGULATION

TEST VALUE UNIT REFERENCE
PROTHROMBIN TIME, PT/INR
PATIENT VALUE 14 Sec 10 - 16
MEAN NORMAL PROTHROMBIN TIME 12.5 Sec
(CONTROL VALUE)
ISI (INTERNATIONAL SENSITIVITY 1.1
INDEX)
INR VALUE 1.13 < 1.30

Note : INR is the parameter of choice in monitoring adequacy of oral anticoagulant therapy. Appropriate therapeutic range
varies with the disease and treatment intensity. Prolonged INR suggests potential bleeding disorder / bleeding complications.
Results should be clinically correlated. Test conducted on Citrated plasma.

Comments : Prothrombin time measures the extrinsic coagulation pathway which consists of activated Factor VII (VIIa),
Tissue factor and Proteins of the common pathway (Factors X, V, II & Fibrinogen). This assay is used to control long term oral
anticoagulant therapy, evaluation of liver function & to evaluate coagulation disorders specially factors involved in the extrinsic
pathway like Factors V, VII, X, Prothrombin & Fibrinogen.

Recommended Therapeutic range for Oral Anticoagulant therapy

INR 2.0-3.0 : Treatment of Venous thrombosis & Pulmonary embolism, Prophylaxis of Venous thrombosis (High risk
surgery), Prevention of systemic embolism in tissue heart valves, AMI, Valvular heart disease & Atrial fibrillation, Bileaflet
mechanical valve in aortic position

INR 2.5-3.5:
· Mechanical prosthetic valves
· Systemic recurrent emboli

Verified by. Authorised by.

Mr. RAJU MEDISETTI Mr. V RAJESH,
M.Sc(Microbiology),DMLT. Page 2 of 5 M.Sc(Biochemistry), B.Sc MLT.
 Scan to download
202308561
Mr. ABDUL SAMAD
Age / Sex : 29 YRS / M Registered on : 02/12/2024 06:55 PM
Collected on : 02/12/2024 06:55 PM
Referred by : Dr. K ANUPAM GARU (BDS., MDS., (Dental Surgeon))
Received on : 02/12/2024 06:57 PM
Visit ID : : 202308561
Reported on : 03/12/2024 02:54 PM

DEPARTMENT OF ENDOCRINOLOGY
THYROID PROFILE (TOTAL T3, TOTAL T4, TSH) , SERUM
TEST VALUE UNIT REFERENCE
TRI-IODOTHYRONINE (T3, TOTAL) 0.93 ng/mL Adult:0.60-2.10
Method: Chemiluminescent immunoassay (CLIA) 1st Trimester:1.21-3.082nd&3rd
Trimester:1.52-3.62
THYROXINE (T4, TOTAL) 8.44 ug/dl Adult : 5.6-12.6
Method: Chemiluminescent immunoassay (CLIA) 1st Trimester: 7.8-16.2
2nd & 3rd :9.1-18.3
THYROID STIMULATING HORMONE (TSH) 1.12 µIU/mL Adult : 0.35 –5.50
Method: Chemiluminescent immunoassay (CLIA) Newborns: 0.70 - 15.2
Peadiatric:2weeks-4 months
:1.7-9.1
1- 6 years : 0.85 - 6.5
7-12 years : 0.28 – 4.3
Pregnancy:1st Trimester: 0.1-2.5
2nd&3rd Trimester:0.2-3

Note : * Total T3 variation can be seen in other condition like pregnancy, drugs, nephrosis etc. In such cases, Free T3 is
recommended as it is Metabolically active. * Total T4 variation can be seen in other condition like pregnancy, drugs,
nephrosis etc. In such cases, Free T4 is recommended as it is Metabolically active. * TSH reference range during pregnancy
depends on Iodine intake, TPO status, Serum HCG concentration, race, Ethnicity and BMI. TSH Levels are subject to
circadian variation, reaching peak levels between 2-4am and at a minimum between 6-10PM.The variation can be of the
order of 50%,hence time of the day has influence on the measured serum TSH concentrations. Values &amplt;0.03 µIU/mL
need to be clinically correlated due to presence of rare TSH variant in some individuals.

Verified by. Authorised by.

Mr. RAJU MEDISETTI Mr. V RAJESH,
M.Sc(Microbiology),DMLT. Page 3 of 5 M.Sc(Biochemistry), B.Sc MLT.
 Scan to download
202308561
Mr. ABDUL SAMAD
Age / Sex : 29 YRS / M Registered on : 02/12/2024 06:55 PM
Collected on : 02/12/2024 06:55 PM
Referred by : Dr. K ANUPAM GARU (BDS., MDS., (Dental Surgeon))
Received on : 02/12/2024 06:57 PM
Visit ID : : 202308561
Reported on : 03/12/2024 02:54 PM

DEPARTMENT OF SEROLOGY
TEST VALUE UNIT REFERENCE
HIV -TRIDOT 1 & 2
HIV - 1 NEGATIVE
HIV - 2 NEGATIVE
Method: Tridot

Note :

A negative result implies that no Anti HIV – 1 & HIV - 2 antibodies have been detected in the sample by this method. This means that either the patient has
not been exposed to HIV-1 or HIV-2 infection or the sample has been tested during the “WINDOW PHASE” (before the development of detectable levels of
antibodies).
A positive result suggests the possibilities of HIV-I and / or HIV-II infection. However these results must be verified by a confirmatory test (IFA / WESTERN
BLOT I-II) before pronouncing the patient positive for HIV-1 and / or HIV-2 infection.

HBSAG RAPID (HEPATITIS B SURFACE NEGATIVE

ANTIGEN)
Method: Rapid kit

Note :

A Negative result does not preclude the possibility of infection with HBV. Other clinically available tests are required if questionable result are
obtained. As with all diagnostic tests, a definitive clinical diagnosis should not be based on the result of single test, but should only be made by
the physician after all clinical and laboratory findings have been evaluated.

HCV - TRIDOT (HEPATITIS C VIRUS) NEGATIVE

Method: Tridot

Note :

The 4th Generation HCV TRI-DOT detects anti-HCV in human serum or plasma and is only a screening test. All reactive samples should be
confirmed by supplemental assays like RIBA. Therefore for a definitive diagnosis, the patient’s clinical history, symptomatology as well as
serological data, should be considered.

TPHA (TREPONEMA PALLIDUM NEGATIVE

HEMAGGLUTINATION), SERUM
Method: Rapid kit

Verified by. Authorised by.

Mr. RAJU MEDISETTI Mr. V RAJESH,
M.Sc(Microbiology),DMLT. Page 4 of 5 M.Sc(Biochemistry), B.Sc MLT.
 Scan to download
202308561
Mr. ABDUL SAMAD
Age / Sex : 29 YRS / M Registered on : 02/12/2024 06:55 PM
Collected on : 02/12/2024 06:55 PM
Referred by : Dr. K ANUPAM GARU (BDS., MDS., (Dental Surgeon))
Received on : 02/12/2024 06:57 PM
Visit ID : : 202308561
Reported on : 03/12/2024 02:54 PM

Note :

Syphilis is a chronic infection that progresses through distinct stages namely Primary, Secondary, Tertiary & Quarternary producing diverse clinical
symptoms. The infection is caused by the Spirochaete Treponema acquired usually by sexual contact although the disease may be transmitted through blood
transfusion and intra-uterine infection. Positive results indicate both past or present infections. False positive results are seen in patients suffering from
Leprosy, Infectious mononucleosis and Connective tissue disorders. This test does not distinguish between Syphilis and other pathogenic treponemal
infections. All positive results should be confirmed with FTA-ABS ( Fluorescent Treponemal Antibodies) test.

~~~ End of report ~~~

Verified by. Authorised by.

Mr. RAJU MEDISETTI Mr. V RAJESH,
M.Sc(Microbiology),DMLT. Page 5 of 5 M.Sc(Biochemistry), B.Sc MLT.